申请人:BERNOTAS Ronald Charles
                            
                            
                                公开号:US20080114023A1
                            
                            
                                公开(公告)日:2008-05-15
                            
                            The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
                            本发明提供一种公式I的化合物以及其在治疗与或受5-HT6受体影响的疾病方面的应用。